ADMA Biologics, Inc. (ADMA)
NASDAQ: ADMA · Real-Time Price · USD
10.52
+0.27 (2.63%)
At close: May 1, 2026, 4:00 PM EDT
10.52
0.00 (-0.01%)
After-hours: May 1, 2026, 7:59 PM EDT

Revenue

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016FY 2015FY 2014FY 2013FY 2012
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16 Dec '15 Dec '14 Dec '13 Dec '12
ADMA BioManufacturing Revenue
493.00M415.81M
ADMA BioManufacturing Revenue Growth
18.57%66.50%
Plasma Collection Centers Revenue
17.03M10.51M
Plasma Collection Centers Revenue Growth
62.11%26.05%
License Revenue
143.00K143.00K
Revenue (Other)
--
Revenue (Total)
510.17M426.45M
Revenue (Total) Growth
19.63%65.16%

Revenue by Geography

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016FY 2015FY 2014FY 2013FY 2012
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16 Dec '15 Dec '14 Dec '13 Dec '12
United States Revenue
504.07M410.15M
United States Revenue Growth
22.90%67.49%
International Revenue
6.11M16.31M
International Revenue Growth
-62.55%22.29%
Revenue (Other)
--
Revenue (Total)
510.17M426.45M
Revenue (Total) Growth
19.63%65.16%

EBT

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016FY 2015FY 2014FY 2013FY 2012
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16 Dec '15 Dec '14 Dec '13 Dec '12
ADMA BioManufacturing Income Before Taxes
230.65M173.14M
ADMA BioManufacturing Income Before Taxes Growth
33.22%266.30%
Plasma Collection Centers Income Before Taxes
-5.36M-5.04M
Updated Dec 31, 2025. Data Source: Fiscal.ai.